Saltsjöbaden, Sweden

Elin Gunneriusson

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 49(Granted Patents)


Location History:

  • Lidingö, SE (2011)
  • Satlsjöbaden, SE (2018)
  • Saltsjobaden, SE (2012 - 2023)
  • Saltsjöbaden, SE (2015 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Elin Gunneriusson: Innovator in Biotherapeutics

Introduction: Elin Gunneriusson, based in Saltsjöbaden, Sweden, is a prominent inventor with a remarkable portfolio of 19 patents. His work predominantly focuses on biotherapeutics, significantly impacting the fields of medicine and diagnostics.

Latest Patents: Among his latest innovations, Gunneriusson has developed C5 binding polypeptides that specifically target the human complement C5. This invention includes a unique C5 binding motif, with a specified amino acid sequence, aimed at potential therapeutic applications for C5-related conditions. Additionally, he has contributed to the creation of imaging agents that incorporate isolated polypeptides conjugated with radionuclides and chelators, designed to bind specifically to HER2. These agents represent significant advances in diagnostic imaging techniques.

Career Highlights: Throughout his career, Gunneriusson has made substantial contributions to the field of biopharmaceuticals while working with notable companies such as Affibody and General Electric Company. His work has not only showcased his inventive prowess but has also propelled advancements in therapeutic and diagnostic methodologies.

Collaborations: Collaboration has been key to Gunneriusson's success. He has worked alongside esteemed colleagues such as Malin Lindborg and Joachim Feldwisch, which has facilitated the rapid development and application of his inventions in real-world contexts.

Conclusion: Elin Gunneriusson is a distinguished figure in the realm of innovative biopharmaceuticals. His numerous patents embody a commitment to advancing therapeutic solutions and diagnostic technologies, positioning him as a leading inventor in his field. With a robust portfolio and impactful collaborations, Gunneriusson continues to contribute significantly to the landscape of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…